|
|
|
Clinical Trials - Emergency Access to Patient Information
MedicAlert® has teamed with RapidTrials® to Offer New Safety Measures for Clinical Trial Participants
In a move to dramatically improve the safety of clinical trial participants in an emergency, MedicAlert Foundation International has entered into an exclusive agreement with RapidTrials, a clinical trial accelerator firm, to provide emergency medical information services to the drug development segment of the life sciences industry.
Major Benefits to Sponsors of Clinical Trials:
- Save lives when a Serious Adverse Event (SAE) occurs.
- Ensure accurate, immediate, and seamless communication between a study subject's family, physician investigator, study coordinator and the emergency responder.
- Provide mechanism for comprehensive safety data capture immediately following the emergency medical intervention.
- Facilitate Study Coordinator Data Capture from emergency care providers' Medical Records, so that your safety team and clinical team are in coordination.
The first-of-its-kind safety program is designed to help ensure clinical trial participants receive proper care and avoid adverse drug interactions that could endanger their health. Due to the secretive nature of blinded clinical trials, emergency responders are often unaware of risks posed by unforeseen drug interactions or medical interventions they may give to study patients.
The improved communication channels between emergency responders and physician researchers will also help prevent or reduce delays in the approval process of new and better medications. The program safeguards patient confidentiality and helps trial sponsors identify and evaluate more quickly the safety profiles of medicines being tested.
|
|
|
|
|
|
